E levated blood pressure (BP) is found in more than every fourth adult 1 and is globally the most important risk factor for stroke. 2 Half of the stroke deaths are thought to be related to high BP, 3, 4 and lowering BP reduces stroke or recurrent stroke in elderly patients. 5, 6 In acute ischemic stroke, the BP is elevated after the stroke in most patients, ≤75%. In addition to admission BP levels, the direction and magnitude of BP change over the first 2 days has been associated with the outcome.
Stroke
June 2016 a first-ever ischemic stroke and the risk of a recurrent stroke, cardiac events, or death from any cause.
Materials and Methods
This retrospective study was approved by the relevant authorities and performed at the Department of Neurology, Helsinki University Hospital. Our hospital has the only comprehensive stroke center with a neurological emergency room in the Helsinki region serving a population of 1.5 million. Patients included in the study belong to the Helsinki Young Stroke Registry (n=1008) and had a first-ever acute ischemic stroke diagnosed and treated at our department from 1994 to 2007. 15 The BP medication information was gathered from patient records and prescriptions data at 3 months time point to exclude patients using the medication only at the acute stroke phase.
All patients included in the study had admission and 24-hour BP values and data on long-term follow-up. BP measurements were performed with fully automatic arm BP monitors with the patient lying in a supine position. Systolic BP (SBP) and diastolic BP (DBP) were recorded at admission in the emergency room and again at 24 hours after stroke onset. When >1 BP measurements were available, the first recording was taken into account for the analysis. Pulse pressure (PP) was calculated as SBP−DBP. Mean arterial pressure was calculated as DBP+1/3 PP. The difference between the admission and 24-hour BP values was calculated as delta (Δ) SBP, DBP, PP, and mean arterial pressure.
Demographic factors analyzed included age and sex. Comorbidities considered were diagnosed hypertension, obesity defined as a body mass index ≥30 kg/m 2 , or patient clearly stated as heavily obese if body mass index data were not available, smoking, dyslipidemia, previous transient ischemic attack, known atrial fibrillation, type 1 or type 2 diabetes mellitus, and cardiovascular disease, including congestive heart failure, coronary artery disease, prior myocardial infarction, or peripheral arterial disease. Classification of the cause of stroke was based on medical and radiological data and was assessed by stroke neurologists according to the Trial of Org 10172 in Acute Stroke Treatment criteria. Hypertension was defined according to World Health Organization criteria: SBP ≥140 mm Hg, DBP ≥90 mm Hg, or patient being on antihypertensive treatment. 16 Follow-up data until the end of 2011 were obtained from the Care Register for Healthcare, maintained by the National Institute for Health and Welfare in Finland. This register is mandatory and regulated by legislation and includes data on all in-hospital stays. All hospitalizations because of International Statistical Classification of  Diseases-9 codes 391-398, 402, 404, 410-417, 420-437, 440-444,  446-447, 449, 451-453, 459, and 798, as well as International  Statistical Classification of Diseases-10 codes I01, I02, I05-I09, I11,  I13, I20-I28, I30-I52, I60-I68, and I70-I79 were screened and diagnoses verified from original patient records when possible. Dates and causes of death came from Statistics Finland. The reliability and quality of these registers have previously been validated. 17, 18 The primary outcome measure was recurrent stroke, defined as any hemorrhagic or ischemic cerebrovascular event corresponding to the aforementioned diagnosis codes, with an exception for transient ischemic attack, which was not included. Secondary outcome measures were death from any cause and composite of cardiac events, defined as an acute myocardial infarction, unstable angina pectoris, coronary revascularization procedure, hospitalization because of other cardiac disease, such as arrhythmia, cardiomyopathy, or congestive heart failure, or death because of cardiac causes, whichever occurred first.
Statistical Analyses
To characterize the patient population, BP parameters were studied in subgroups defined by age and sex. Because we had only few young patients and the number of patients increased with age, we used age percentiles to have an almost equal number of patients in each group. Median and interquartile range were reported for non-normally distributed parameters. Chi-square tests were used to compare categorical variables. Student's t and Mann-Whitney U tests allowed comparisons of normally distributed continuous and non-normally distributed or noncontinuous variables, respectively. With each patient, the median differences between admission and 24-hour values were tested with Wilcoxon signed-rank test.
The cutoff SBP and DBP levels were visually estimated from the Cox regression cumulative survival curve in both patients with or without antihypertensive medication. Multivariable Cox regression analysis was used to identify the independent BP parameters associated with the outcomes. For each BP parameter, a separate multivariable analysis was performed after adjustment for age, sex, previous transient ischemic attack, dyslipidemia, type 1 and type 2 diabetes mellitus, cardiovascular disease, obesity, and current smoking; selection was based on their univariate significance (P<0.10). Cumulative distribution of the Kolmogorov-Smirnov test was analyzed on patients with and without recurrent stroke and admission SBP and DBP decentiles.
A 2-sided P value <0.05 was considered statistically significant. All statistical analyses were done on IBM SPSS 19.0.
Results
A total of 1004 eligible patients were included in the study (44 [37-47] years). Median delay to the first imaging was 0 days (interquartile range 0-2). Most patients were men (63%) having hypertension significantly more often than women (44% versus 31%; P<0.001).
Increased SBP levels ≥140 mm Hg at admission were found in 57% (n=549) of the patients. Male preponderance, BP levels, and cardiovascular risk factors, such as hypertension (n=393, 39%), increased significantly with age (Table I in the online-only Data Supplement). Patients with a recurrent stroke had higher BP levels both at admission and at 24 hours; the BP levels decreasing significantly within 24 hours (Table 1) .
One in 3 used antihypertensive medication (n=358, 36%) within 3 months: β-blockers (57%), angiotensin-converting Figure 1 ). A recurrent stroke during follow-up occurred in 142 patients (14%; 65% male); most recurrent strokes being ischemic (n=123, 12%) and only few (n=19, 1.9%) hemorrhagic. Composite of cardiac events were seen in 149 patients (15%), and AMI occurred in 37 patients (3.7%; 89% male). Vascular death was seen in 42 patients (4.2%; 78% male) out of all the 178 deaths (18%) from any cause.
Patients with an admission SBP ≥160 mm Hg compared with patients with an SBP <160 mm Hg had significantly more recurrent strokes in all the patients; in both patients with and without antihypertensive treatment ( Figure 1 ). The recurrent strokes also occurred earlier (13.9 [13. 
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June 2016 associated with a significantly higher recurrent stroke risk is seen in Figure 2 . In multivariable Cox regression analyses, higher admission SBP, DBP, PP, mean arterial pressure, and ΔSBP levels were independently associated with an increased recurrent stroke risk (Table 2) after adjusting for age, sex, previous transient ischemic attack, type 1 and type 2 diabetes mellitus, obesity, hyperlipidemia, and current smoking. No association was found for ΔDBP, ΔPP, Δmean arterial pressure, or 24-hour BP levels and recurrent stroke or for any BP levels and death from any cause or any cardiac event (data not shown).
Discussion
High admission BP levels were found in more than half of our young patients with acute stroke. These high BP levels were independently associated with a higher risk of recurrent strokes in the long-term follow-up, being in line with earlier reports with older stroke patients. 6 There was a cutoff level of BP >160/100 mm Hg on admission, which lead to significantly more recurrent strokes than the lower BP levels. Hypertension was a relatively rare diagnosis before stroke, and the diagnosed patients had few hypertensive years behind; in addition, the elevated BP levels decreased within 24 hours close to normal being no more associated with recurrent strokes. Low admission BP, on the other hand, was found in only 4.5% of our young patients, probably because of few patients having impaired cardiac output, secondary to cardiac failure, AMI, or arrhythmias, found more in older stroke patients. 19 The underlying mechanisms of elevated BP in ischemic stroke are not yet well understood, although several mechanisms have been suggested, such as preexisting hypertension, oxidative stress, activation of the sympathetic renin-angiotensin-aldosterone, cortisol, and natriuretic peptide neuroendocrine systems, and the Cushing reflex, that is, raised BP secondary to raised intracranial pressure. 19 In acute stroke, cerebral blood flow depends on systemic arterial pressure when cerebral autoregulation is impaired because of regional hypoxia and acidosis, resulting in reduced penumbral perfusion. Transcranial Doppler has been used to study impaired cerebral autoregulation 20 ; however, not all studies using other methods have found evidence of the impaired cerebral autoregulation. 21 The management of BP in the acute stroke phase is, consequently, still unclear, 22, 23 with limited evidence to evaluate the effect of altering BP. 19 Ischemic stroke patients have been shown to have their acute postevent SBP closer to premorbid levels, with no BP level rise before the event, unlike patients with hemorrhagic stroke. 24 Most recommendations, therefore, avoid routine BP lowering in the acute phase of ischemic stroke 23 because it could be harmful 25 because of an inadequate supply of blood in the brain. Initiation of antihypertensive therapy has mostly been associated with a favorable outcome in case of intraventricular thrombolysis. 26 In a meta-analysis, lowering the BP reduced the stroke rate in everyone >60 years of age, no matter what the baseline BP level. 5 In a post analysis of a subacute stroke prevention trial, only one third of the patients had controlled BP ≥75% of the time, which was linked to reduction in recurrent stroke. 6 In our study, there was no difference found between patients with or without antihypertensive medication at 3 months in predicting recurrent stroke during the 18-year follow-up. There might be several explanations for this result. The lack of association of BP variability during the acute phase may relate to bed rest and acute therapy. Our patients might have had uncontrolled BP like most patients in the stroke prevention trial, or the young patients getting older might instead have been using more antihypertensive medication later on, after the 3 months. The patients in the stroke prevention trial having controlled BP most of the time were younger, had lower body mass index and cholesterol levels, and had less history of diabetes mellitus. 6 It, thus, seems to be important in the young to emphasize also on the lifestyle modifications, such as obesity, diabetes mellitus, hyperlipidemia, and smoking in preventing recurrent strokes.
Our study has limitations because it was conducted in a retrospective manner without predefined study protocol for the BP measurements, and pre-event BP levels were not available. The cohort also represents a solely white population, and thus, the results may not be directly generalizable to other ethnic populations with a different profile of BP.
The strengths of the study include the large number of patients enrolled and the ability to stratify the impact of the antihypertensive use. The patients were prospectively assessed with standardized measures over a 13-year period. Given the wide catchment area for our stroke unit, the registry has likely captured most young stroke patients, and because of the surveillance system for medication, recurrent events and deaths have likely been near complete over the median of a 9-year follow-up, with limited referral or outcome assessment bias.
The study highlights the prognostic importance of hypertension at the time of the initial stroke, in terms of a relationship with recurrent events, with only 30% of patients on antihypertensive therapy within 3 months. Given the near linear association of BP levels and the risk of recurrent vascular events, this study highlights an unmet need where all young patients with acute stroke should take BP-lowering medication irrespective of initial BP levels. Although the young have stroke risk factors differing from the elderly, this article reemphasizes the importance of BP control in the long-term, and that hypertension in the acute stroke phase highlights a need for intensive BP-lowering therapy because of its prognostic prediction in terms of major recurrent cardiovascular events. In our cohort with a mean age of 44 years, 1 in 7 had a recurrent stroke, and 1 in 5 died, over the subsequent several years.
Conclusions
This study brings new clinically useful information about the impact on outcome of admission BP levels in young adults having acute, first-ever ischemic stroke. In the young ischemic stroke patients, high acute-phase BP levels were independently associated with a high risk of recurrent strokes. There was a cutoff level of BP >160/100 mm Hg at admission, leading to significantly more recurrent strokes than with lower levels.
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